Clinical trial
Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI).
NCT03404063 is registered in ClinicalTrials.gov with John Paul II Hospital, Krakow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regeneration of Ischemic Damages in Cardiovascular System Using Wharton's Jelly as an Unlimited Source of Mesenchymal Stem Cells for Regenerative Medicine. Project of the National Centre for Research and Development (Poland) 'STRATEGMED II'. Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI).
- Lead sponsor
- John Paul II Hospital, Krakow
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 20, 2017
- Completion date
- March 31, 2021
- Enrollment
- 105 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.